Armando Salim Munoz Abraham

Dr. Armando Salim Munoz Abraham

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2015 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
YNYael R. Nobel
Yael R. Nobel
KFKimberly A. Forde
Kimberly A. Forde
LWLinda Wood
Linda Wood
KCKatarzyna Cartiera
Katarzyna Cartiera
AAArmando Salim Munoz Abraham
Armando Salim Munoz Abraham
DGDavid S. Goldberg
David S. Goldberg
Living donor liver transplantation (LDLT) is a comparable alternative to deceased donor liver transplantation and can mitigate the risk of dying while waiting for transplant. Although evidence exists of decreased utilization of living donor kidney transplants among racial minorities, little is known about access to LDLT among racial/ethnic minorities. We used Organ Procurement and Transplantation Network/United Network for Organ Sharing data from February 27, 2002 to June 4, 2014 from all adult liver transplant recipients at LDLT‐capable transplant centers to evaluate differential utilization of LDLTs based on race/ethnicity. We then used data from 2 major urban transplant centers to analyze donor inquiries and donor rule‐outs based on racial/ethnic determination. Nationally, of 35,401 total liver transplant recipients performed at a LDLT‐performing transplant center, 2171 (6.1%) received a LDLT. In multivariate generalized estimating equation models, racial/ethnic minorities were significantly less likely to receive LDLTs when compared to white patients. For cholestatic liver disease, the odds ratios of receiving LDLT based on racial/ethnic group for African American, Hispanic, and Asian patients compared to white patients were 0.35 (95% CI, 0.20–0.60), 0.58 (95% CI, 0.34–0.99), and 0.11 (95% CI, 0.02–0.55), respectively. For noncholestatic liver disease, the odds ratios by racial/ethnic group were 0.53 (95% CI, 0.40–0.71), 0.78 (95% CI, 0.64–0.94), and 0.45 (95% CI, 0.33–0.60) respectively. Transplant center‐specific data demonstrated that African American patients received fewer per‐patient donation inquiries than white patients, whereas fewer African American potential donors were ruled out for obesity. In conclusion, racial/ethnic minorities receive a disproportionately low percentage of LDLTs, due in part to fewer initial inquiries by potential donors. This represents a major inequality in access to a vital health care resource and demands outreach to both patients and potential donors. Liver Transpl 21:904‐913, 2015. © 2015 AASLD.

25 September 2018 in Children
Verified
Journal Article
Open access
PDF file
CDChristine Denton
Christine Denton
APAmber Price
Amber Price
JFJulie Friend
Julie Friend
CMChandrashekhara Manithody
Chandrashekhara Manithody
KBKeith Blomenkamp
Keith Blomenkamp
AJAjay Jain
Ajay Jain
For decades, parenteral nutrition (PN) has been a successful method for intravenous delivery of nutrition and remains an essential therapy for individuals with intolerance of enteral feedings or impaired gut function. Although the benefits of PN are evident, its use does not come without a significant risk of complications. For instance, parenteral nutrition-associated liver disease (PNALD)—a well-described cholestatic liver injury—and atrophic changes in the gut have both been described in patients receiving PN. Although several mechanisms for these changes have been postulated, data have revealed that the introduction of enteral nutrition may mitigate this injury. This observation has led to the hypothesis that gut-derived signals, originating in response to the presence of luminal contents, may contribute to a decrease in damage to the liver and gut. This review seeks to present the current knowledge regarding the modulation of what is known as the “gut–liver axis” and the gut-derived signals which play a role in PN-associated injury.

1 February 2016 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
AAArmando Salim Munoz Abraham
Armando Salim Munoz Abraham
RPRoger Patrón-Lozano
Roger Patrón-Lozano
RNRaja Narayan
Raja Narayan
SJSami S. Judeeba
Sami S. Judeeba
AAAbedalrazaq Alkukhun
Abedalrazaq Alkukhun
MRManuel I. Rodríguez-Dávalos
Manuel I. Rodríguez-Dávalos

1 August 2015 in Journal of Surgical Research
Verified
Journal Article
Closed access
AAArmando Salim Munoz Abraham
Armando Salim Munoz Abraham
SJSami Judeeba
Sami Judeeba
AAAbedalrazaq Alkukhun
Abedalrazaq Alkukhun
TATariq Alfadda
Tariq Alfadda
RPRoger Patron-Lozano
Roger Patron-Lozano
JGJohn Geibel
John Geibel

1 October 2019 in Pediatrics & Neonatology
Verified
Journal Article
Open access
FBFaidah Badru
Faidah Badru
NPNicholas Piening
Nicholas Piening
AAArmando Salim Munoz Abraham
Armando Salim Munoz Abraham
HOHector Osei
Hector Osei
JGJose Greenspon
Jose Greenspon
GVGustavo A. Villalona
Gustavo A. Villalona
Background: To compare outcomes for complicated appendicitis treated with early versus interval appendectomy and to identify which patients would likely benefit from early appendectomy. Methods: A retrospective review of complicated appendicitis was performed from 2010 to 2015. Patients were divided into early (EA) versus interval appendectomy (IA) groups. We compared demographics, complications and outcomes. Pearson's Chi square analysis and Student's T test analysis were performed. Results: We identified 316 patients (EA group 53% vs. IA group 47%). Interval appendectomy group had longer symptom duration [IA 3.8 vs. EA 2.3 days (p = 0.0001)], increased leukocytosis [IA 18.7 vs. EA 17.2 (p = 0.008)], more initial abscesses [IA 35% vs. EA 13% (p = 0.0001)], more complications [IA 30% vs. EA 19%, (p = 0.013) and prolonged total length of stay [(LOS), p = 0.009]. Subgroup analysis of all patients revealed 80% of patients presented with <= 3 cm abscess and duration of symptoms (DOS) <= 5 days. Interval appendectomy patients with DOS <= 5 days and or <= 3 cm abscess on admission had no differences in clinical presentation. However, these patients had prolonged total LOS (IA 7.7 vs. EA 6.3 days, p = 0.01) and increased complications (IA 29% vs. EA 19%, p = 0.04). Conclusion: The majority of patients with complicated appendicitis in children present with small abscess (<= 3 cm) and short symptom duration (<= 5 days). This subset of patients might benefit from early appendectomy due to decreased LOS, resource utilization and reduced complications. Copyright (C) 2019, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.

1 June 2017 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
AAAbedalrazaq AlKukhun
Abedalrazaq AlKukhun
GCGiorgio Caturegli
Giorgio Caturegli
AAArmando Salim Munoz Abraham
Armando Salim Munoz Abraham
SJSami Judeeba
Sami Judeeba
RPRoger Patron-Lozano
Roger Patron-Lozano
JGJohn Geibel
John Geibel
Fluorescein isothiocyanate-inulin can be used as a real-time volume marker to monitor the ischemic state of intestinal tissue. A positive correlation between the degree of fluid shift and presence of ischemic injury. The changes in fluorescence signal provide a potential selective method to measure real-time fluid changes inside an intestinal graft to evaluate viability.